TP53 and animal viral hepatitis: Moreover, GSEA demonstrated significant suppression of oncogenic processes such as "Viral hepatitis", "Cell growth regulation", "EMT", and "P53 signaling" in MALAT1-silenced cells (Fig. S3F-I).